Acquired Company

Phytanix Bio, Inc. completed the acquisition of Protagenic Therapeutics, Inc. in a reverse merger on 5/16/2025.

Protagenic Therapeutics, Inc. operates as a pharmaceutical company specializing in the development of medicines manufactured from cannabinoid and cannabinoid-like molecules. Protagenic Therapeutics, Inc. was founded in 2004 and is based in Santa Barbara, California. Show more

701 Anacapa Street, Santa Barbara, CA, 93101, United States

Biotechnology

Healthcare

Start AI Chat

Market Cap

867.6K

52 Wk Range

$0.25 - $14.28

Previous Close

$0.42

Open

$0.43

Volume

5,735

Day Range

$0.43 - $0.50

Enterprise Value

6.236M

Cash

2.722M

Avg Qtr Burn

-1.395M

Insider Ownership

3.59%

Institutional Own.

6.91%

Qtr Updated

09/30/25

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.

Drug & Indication	Stage & Event	Catalyst Date
PT00114 Details Major depression, anxiety disorders, PTSD, addiction / substance use disorders	Phase 2 Initiation	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.